Genedrive PLC’s MT-RNR1 ID kit has received a final recommendation from the UK's National Institute for Health and Care Excellence (NICE) meaning it can be used by the NHS.
.........................
They already received the best recommendation they could have got.
RE: 100,000 share Buy at the close21 Aug 2023 18:08
I would love a takeover offer of 123p a share. If you look at the products they have, it seems a no brainer for a huge takeover bid as it would pay for itself in the future.
RE: New bottom watch alert activated18 Aug 2023 10:49
Well Avacta hit £1.80+ and has terrible fundamentals and as a business is much worse than Genedrive so its all about luck. Genedrive was 48p this year but now they have progressed massively since, it hit even 10's so AIM is all about luck.
I have a feeling it will rocket past 35p tomorrow. GLA! The buys today makes me feel some huge news is due. A huge well deserved rerate on the cards. :)
Funny you bashed a stock which is in a much better position and the share that is in a terrible position, you say results are great. Shows your agenda.
The Genedrive MT‑RNR1 ID kit costs £100 (excluding VAT). The cost per test used in the economic model (incorporating additional cost components such as purchase of the Genedrive machine, printing costs, control tests, warranty and staff costs) was £130.08.